• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: November 19-23, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

November 19-23, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs11/20/12Silver Spring, MDMichael Taylor, Lisa Dwyer, Jessica Leighton, Claudine Kavanaugh, Kari Barett, Kristy Moran, Michelle Williams-EllerbeGary Rodkin, Al Bolles (ConAgra Foods, Inc.)Food Safety and Portion Control
John M. Taylor, III, J.D., Counselor to the Commissioner11/20/12Washington, DC Rebecca Buckner, Donald KraemerSara Schaumber (Rep. Ed Markey [D-MA]); Rachel McCleery (Rep. John Dingell [D-MI]; Emily Katz (Rep. Diana DeGette [D-CO]); Tom Power (Rep. Cliff Stearns [R-FL]); Whitney Brown (Rep. John Sarbanes [D-MD]; Rebekah Armstrong (Rep. Michael Burgess [R-TX)]); Karen Summar (Rep. Cathy McMorris Rodgers [R-WA]); Allison Witt (Rep. Bob Latta [R-OH]); Adam Harbison (Rep. Morgan Griffith [R-VA]); Clay Alspach (R-House Energy and Commerce); Rachel Sher (D-House Energy and Commerce); Eric Flamm (D-House Energy and Commerce/Food and Drug Administration); Tiffany Guarascio (Rep. Frank Pallone [R-NJ]House Energy and Commerce Committee Staff Briefing on the status of the Food Safety Modernization Act 
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Chief Counsel11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Walter Harris, Chief Operating Officer11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Peter Lurie, Acting Associate Commissioner for Policy and Planning11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Michele Mital, Acting Associate Commissioner for Legislation11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Melinda Plaiser, Acting Associate Commissioner for Regulatory Affairs11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Mary Lou Valdez, Associate Commissioner for International Programs11/19/12-11/21/12Buenos Aires, ArgentinaIlisa BernsteinN/AWHO Member State Mechanism for Substandard/Spurious/Falsely-Labelled/Faslified/Counterfeit (SSFFC) Medical Products
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs11/19/12-11/23/12N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research11/19/12-11/23/12N/AN/AN/ANo Significant Meetings